US Patent Issued to Shinkei Therapeutics on Oct. 6 for "Parenteral treatments involving aminoadamantane derivatives" (American, Indian Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,934, issued on Oct. 6, was assigned to Shinkei Therapeutics Inc. (Princeton, N.J.).

"Parenteral treatments involving aminoadamantane derivatives" was invented by Gurpartap Singh Sachdeva (Princeton Junction, N.J.), Suresh Borsadia (Plainsboro, N.J.), Kalpana Patel (West Windsor, N.J.) and Krunal Raval (Ahmedabad, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method and composition is described for treating impaired neurological function, CNS disease or condition, including altered state of consciousness disorders in a human subject, comprising parenterally administering a composition comprising aminoadamantane derivatives or salts thereof, a...